Photodynamic therapy for dysplastic Barrett's oesophagus: A prospective, double blind, randomised, placebo controlled trial

Gut

Volumn 47, Issue 5, 2000, Pages 612-617

  Ackroyd, R ^a   Brown, N J ^a   Davis, M F ^b   Stephenson, T J ^b   Marcus, S L ^c   Stoddard, C J ^a   Johnson, A G ^a   Reed, M W R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c DUSA Pharmaceuticals Inc   (United States)

Author keywords

Aminolaevulinic acid; Barrett's oesophagus; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; ANESTHETIC AGENT; MIDAZOLAM; OMEPRAZOLE; PETHIDINE; PLACEBO; PROPOFOL; PROTON PUMP INHIBITOR;

ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESOPHAGUS CANCER; GASTROINTESTINAL ENDOSCOPY; HUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; THORAX PAIN; TREATMENT OUTCOME;

ADULT; AGED; AMINOLEVULINIC ACID; ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ESOPHAGOSCOPY; FEMALE; HUMANS; LASERS; MALE; MIDDLE AGED; OMEPRAZOLE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 0033756101     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.5.612     Document Type: Article

References (24)

1. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus
2. Adenocarcinoma and Barrett's esophagus: An overrated risk?
3. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus
4. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus
5. Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery
6. Barrett's esophagus: Comparison of benign and malignant cases
7. A case of Barrett's epithelialisation followed up for 5 years
8. Selective management of benign esophageal strictures
9. Barrett's oesophagus
10. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus
11. Photodynamic therapy for Barrett's esophagus: Follow-up in 100 patients
12. Photosensitization and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5-aminolaevulinic acid induced protoporphyrin IX - A pilot study
13. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX
14. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid
15. Photodynamic therapy (PDT) for Barrett's oesophagus: A dosimetric pilot study
16. Photodynamic therapy (PDT) for Barrett's oesophagus: Establishing optimal treatment parameters
17. Barrett's esophagus, dysplasia, and adenocarcinoma
18. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical implications
19. Ablation therapy for Barrett oesophagus: What depth of tissue destruction is needed?
20. Regression of Barrett's esophagus by laser ablation in an antacid environment
21. Photothermal laser ablation of Barrett's oesophagus: Endoscopic and histological evidence of squamous re-epithelialisation
22. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus
23. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results
24. Endoscopic argon beam plasma coagulation in the restoration of squamous lining in Barrett's oesophagus